City
Epaper

1.1 cr Covidshield vaccines procured for Rs 200 per dose, 55L Covaxin for Rs 206 apiece

By IANS | Published: January 12, 2021 5:14 PM

New Delhi, Jan 12 Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health ...

Open in App

New Delhi, Jan 12 Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively.

"As many as 110 lakh (1.1 crore) doses of Covishield vaccine are being procured from the Serum Institute of India at a cost of Rs 200 per dose, excluding taxes. A total of 55 lakh doses of Covaxin vaccine are being procured from Bharat Biotech," Union Health Secretary Rajesh Bhushan said during a press conference.

The cost of 38.5 lakh doses of Covaxin is Rs 295 per dose, excluding taxes. Bharat Biotech is providing 16.5 lakh doses of Covaxin free of cost to the Central government. Hence, the cost of Covaxin comes to Rs 206 per dose," he added.

Vaccines have already reached some states. Till 4 p.m., about 54,72,000 doses were received by the states and Union Territories. By January 14, 100 per cent doses will be received.

The much-awaited Covid-19 vaccination drive will kick-off on January 16. The Central government plans to vaccinate nearly 30 crore people in the first phase of the drive. Priority will be given to the healthcare and frontline workers who are estimated to be around three crore, followed by those above 50 years of age and the under-50 population with comorbidities numbering around 27 crore.

On January 3, two vaccines Bharat Biotech's Covaxin and Oxford-AstraZeneca's Covishield manufactured by the Serum Institute of India were approved for 'restricted emergency use'. Few more vaccines are in the pipeline and are conducting trials.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: United StatesRajesh bhushanNew DelhiUnion Health MinistrySerum Institute Of IndiaThe new delhi municipal councilDelhi south-westSerum institute of india pvt. ltdSerum india
Open in App

Related Stories

NationalNew Delhi: 18-Year-Old Stabbed to Death by Two Individuals Over Romantic Rivalry

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

Social ViralCovishield Funny Memes Go Viral After AstraZeneca Admits Its COVID-19 Vaccine Can Cause Rare Side Effects

NationalSunita Kejriwal, Atishi Meet Delhi CM Arvind Kejriwal in Tihar Jail

NationalNew Delhi: A 12-Year-Old Boy Got Electrocuted After He Came in Contact With a Bombay Suburban Electric Supply

Health Realted Stories

HealthFSSAI terms reports of allowing 10x more MRL in herbs, spices 'baseless'

HealthPediatric cancer Patients and their families ‘Second Home’ away from Home

HealthNew Covid variant 'FLiRT' capable of evading the immune system: Experts

HealthSouth Korean govt appears to shelve punitive measures against mass walkout by doctors

HealthCipla, Glenmark recall drugs in US due to manufacturing issues